Table 2

Serum and Cytological Fluid Levels for CTFRA 21–1, CEA, and SCC in 194 Patients with Malignant and Benign Lesions
Tumor marker Malignant (n=139) Benign (n=55) p-value
Serum
CYFRA 21–1 (ng/mL) 8.36 ± 26.87 2.30 ± 1.23 0.097
CEA (ng/mL) 31.86 ± 93.37 2.67 ± 1.87 0.022
SCC (ng/mL) 1.22 ± 1.48 0.78 ± 0.62 0.035
Cytological fluid
CYFRA 21–1 (ng/mL) 111.04 ± 159.59 5.01 ± 3.55 0.001
CEA (ng/mL) 20.63 ± 75.50 0.31 ± 0.48 0.003
SCC (ng/mL) 13.14 ± 33.76 2.84 ± 7.82 0.027

Note-Data are presented as mean ± standard deviation.

Hur et al.

Hur et al. BMC Cancer 2012 12:392   doi:10.1186/1471-2407-12-392

Open Data